Volume 3 Number 3

Website Exclusive Contents!
Exclusive contents: images and/or videos
Editorial
52
At the dawning of interventional cardiology: Andreas Gruentzig, 30 years after
15 September 1977-15 September 2007

EuroInterv.2007;3:293

53
Memories from the dawn of interventional cardiology

EuroInterv.2007;3:295

54
The SCAAR registry or the Swedish yo-yo

EuroInterv.2007;3:297-300

EAPCI column
55
EAPCI: education and training programmes in interventional cardiology today

EuroInterv.2007;3:301-303

Special report
56
EuroPCR 2007 highlights

EuroInterv.2007;3:305-308

Clinical research
57
Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial

EuroInterv.2007;3:309-314

58
One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study

EuroInterv.2007;3:315-320

59
Percutaneous injection of thrombin for the treatment of pseudoaneurysms: the German multicentre registry

EuroInterv.2007;3:321-326

60
A multicentre comparison of transradial and transfemoral approaches for coronary angiography and PTCA in obese patients: the TROP registry

EuroInterv.2007;3:327-332

61
Appraising the effectiveness and safety of paclitaxel-eluting stents in over 1,000 very high-risk patients: overall results of the Taxus in Real-life Usage Evaluation (TRUE) Registry

EuroInterv.2007;3:333-339

62
Economic impact of endarterectomy vs carotid artery stenting: a one year, single centre study

EuroInterv.2007;3:340-344

63
Activation of coagulation during routine diagnostic coronary angiography

EuroInterv.2007;3:345-349

64
Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™

EuroInterv.2007;3:350-358

65
Short- and long-term outcomes of percutaneous coronary interventions in patients with severe left ventricular dysfunction

EuroInterv.2007;3:359-364

66
Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios This article contains pictures and/or videos

EuroInterv.2007;3:365-370

67
Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design

EuroInterv.2007;3:371-380

Expert review
68
Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents

EuroInterv.2007;3:381-385

69
Effectiveness and safety of paclitaxel-eluting stents in patients with ST-segment elevation acute myocardial infarction

EuroInterv.2007;3:386-391

70
A pooled safety analysis of data comparing paclitaxel-eluting stents with bare-metal stents

EuroInterv.2007;3:392-399

71
Prognostic impact of major bleeding in patients with acute coronary syndromes. A systematic review and meta-analysis

EuroInterv.2007;3:400-408

72
Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis

EuroInterv.2007;3:409-415

Technical report
73
vProtect™ luminal shield system This article contains pictures and/or videos

EuroInterv.2007;3:416-419

Volume 3 Number 3 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Boston Scientific
  • Cordis, a Johnson & Johnson company
  • Hexacath
  • Invatec
  • Medtronic
  • Orbus Neich
  • Terumo

Online ISSN 1969-6213 - Print ISSN 1774-024X